ASGN (NYSE:ASGN) Releases Q2 2026 Earnings Guidance

ASGN (NYSE:ASGN) updated its second quarter 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 0.720-0.900 for the period, compared to the consensus earnings per share estimate of 1.280. The company issued revenue guidance of $970.0M-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion.

ASGN Stock Performance

Shares of ASGN opened at $19.46 on Friday. The firm has a market cap of $803.49 million, a P/E ratio of 8.61 and a beta of 0.89. ASGN has a twelve month low of $19.31 and a twelve month high of $60.75. The company has a debt-to-equity ratio of 0.65, a quick ratio of 2.16 and a current ratio of 2.16. The firm’s 50 day moving average price is $39.12 and its two-hundred day moving average price is $44.41.

ASGN (NYSE:ASGN) last issued its quarterly earnings data on Wednesday, April 22nd. The business services provider reported $0.69 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.98 by ($0.29). ASGN had a return on equity of 10.26% and a net margin of 2.46%.The company had revenue of $968.30 million for the quarter, compared to the consensus estimate of $970.48 million. During the same period in the prior year, the company earned $0.92 EPS. The firm’s revenue was up .0% on a year-over-year basis. ASGN has set its Q2 2026 guidance at 0.720-0.900 EPS. On average, analysts forecast that ASGN will post 5.03 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on ASGN shares. BMO Capital Markets cut ASGN from an “outperform” rating to a “market perform” rating and set a $33.00 price objective for the company. in a research report on Thursday. Wall Street Zen lowered ASGN from a “buy” rating to a “hold” rating in a research report on Sunday, March 22nd. Wells Fargo & Company cut their target price on ASGN from $54.00 to $33.00 and set an “equal weight” rating on the stock in a research note on Thursday. Robert W. Baird decreased their price target on shares of ASGN from $62.00 to $38.00 and set a “neutral” rating for the company in a research note on Thursday. Finally, UBS Group lowered their price objective on shares of ASGN from $39.00 to $35.00 and set a “sell” rating on the stock in a report on Thursday. Six equities research analysts have rated the stock with a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, ASGN has an average rating of “Reduce” and a consensus price target of $38.43.

More ASGN News

Here are the key news stories impacting ASGN this week:

• Positive Sentiment: Analysts still see upside from today’s levels — several firms maintain price targets in the low-to-mid $30s (median ~ $33) despite the selloff, which could support a recovery if margins and guidance stabilize. ASGN sinks 50.7% as profit outlook resets after Q1 margin compression and weak Q2 guidance
• Neutral Sentiment: The company’s corporate transition (name/ticker change to Everforth / EFOR) is underway — a mechanical event that can increase volatility and trading volume but does not itself change fundamentals. ASGN Incorporated Reports First Quarter 2026 Results
• Neutral Sentiment: Top-line was essentially in-line: Q1 revenue was $968.3M (roughly matching estimates), showing demand wasn’t the primary issue — the market reaction centers on profitability and outlook. ASGN posts Q1 CY2026 sales in line with estimates but stock drops 24.3%
• Negative Sentiment: Major catalyst: Q1 EPS missed expectations ($0.69 vs. ~$0.98 consensus) and Q2 EPS guidance was cut to $0.72–$0.90 vs. ~$1.28 consensus — a clear reset to near-term earnings expectations. ASGN Incorporated Reports First Quarter 2026 Results
• Negative Sentiment: Margin pressures drove the shock: adjusted EBITDA margin fell to ~8.6% and management cited weaker mix (less higher-margin solutions), acquisition/integration and other elevated costs, plus FX impacts — management flagged continued margin pressure in Q2 guidance. ASGN sinks 50.7% as profit outlook resets after Q1 margin compression and weak Q2 guidance
• Negative Sentiment: Analyst reactions and rating cuts accelerated selling — multiple firms trimmed ratings/targets (including Truist, BMO and others), which increases short-term downside pressure. ASGN tumbles 35 after Truist cuts rating following Q1 miss
• Negative Sentiment: A shareholder law firm announced an investigation into potential claims related to the quarter, a factor that can increase uncertainty and selling pressure while it plays out. ASGN Incorporated Shareholders Are Encouraged to Reach Out to Johnson Fistel

Institutional Trading of ASGN

Institutional investors and hedge funds have recently bought and sold shares of the stock. Parallel Advisors LLC grew its stake in ASGN by 190.8% in the fourth quarter. Parallel Advisors LLC now owns 1,390 shares of the business services provider’s stock valued at $67,000 after purchasing an additional 912 shares in the last quarter. Horizon Investments LLC bought a new stake in shares of ASGN during the 3rd quarter worth approximately $515,000. Russell Investments Group Ltd. boosted its holdings in shares of ASGN by 96.9% in the 3rd quarter. Russell Investments Group Ltd. now owns 30,497 shares of the business services provider’s stock valued at $1,444,000 after buying an additional 15,011 shares during the last quarter. Finally, New South Capital Management Inc. boosted its holdings in shares of ASGN by 39.2% in the 4th quarter. New South Capital Management Inc. now owns 635,011 shares of the business services provider’s stock valued at $30,588,000 after buying an additional 178,895 shares during the last quarter. Institutional investors own 95.36% of the company’s stock.

ASGN Company Profile

ASGN Incorporated (NYSE:ASGN) is a leading provider of specialized staffing and professional services, delivering tailored solutions across information technology, digital transformation, engineering and scientific disciplines. Through its diversified portfolio of brands, ASGN connects clients—ranging from life sciences and healthcare firms to technology enterprises and government agencies—with highly skilled consultants, project teams and permanent personnel. The company’s model emphasizes both temporary staffing and long-term consulting engagements to address complex talent and project needs.

ASGN’s service offerings are organized into two main business segments.